Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Maher

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 11, 2020
COngenital heart disease and the Diagnostic yield with Exome sequencing (CODE) study: prospective cohort study and systematic reviewF Mone, R Y Eberhardt, R K Morris, et al.
Oncogene|September 25, 2007
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancerW N Cooper, R E Dickinson, A Dallol, et al.
Journal of Medical Genetics|September 9, 2000
Recurrent germline mutation in MSH2 arises frequently de novoD C Desai, J C Lockman, R B Chadwick, et al.
Molecular Genetics and Metabolism|October 1, 2011
Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like diseaseE Meyer, M A Kurian, N V Morgan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 19, 2021
Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?R Mellis, R Y Eberhardt, S J Hamilton, et al.
Oncogene|June 2, 2010
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathwaysF E Lock, N Underhill-Day, T Dunwell, et al.
Seminars in Oncology|September 29, 2018
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumabR T Casey, O Giger, I Seetho, et al.
Oncogene|April 21, 2001
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursA Agathanggelou, S Honorio, D P Macartney, et al.
Neurology|April 30, 2008
Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)M A Kurian, N V Morgan, L MacPherson, et al.
Cancer Research|June 30, 2001
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomasM S Wiesener, P M Münchenhagen, I Berger, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 11, 2020
COngenital heart disease and the Diagnostic yield with Exome sequencing (CODE) study: prospective cohort study and systematic reviewF Mone, R Y Eberhardt, R K Morris, et al.
Oncogene|September 25, 2007
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancerW N Cooper, R E Dickinson, A Dallol, et al.
Journal of Medical Genetics|September 9, 2000
Recurrent germline mutation in MSH2 arises frequently de novoD C Desai, J C Lockman, R B Chadwick, et al.
Molecular Genetics and Metabolism|October 1, 2011
Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like diseaseE Meyer, M A Kurian, N V Morgan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 19, 2021
Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?R Mellis, R Y Eberhardt, S J Hamilton, et al.
Oncogene|June 2, 2010
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathwaysF E Lock, N Underhill-Day, T Dunwell, et al.
Seminars in Oncology|September 29, 2018
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumabR T Casey, O Giger, I Seetho, et al.
Oncogene|April 21, 2001
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursA Agathanggelou, S Honorio, D P Macartney, et al.
Neurology|April 30, 2008
Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)M A Kurian, N V Morgan, L MacPherson, et al.
Cancer Research|June 30, 2001
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomasM S Wiesener, P M Münchenhagen, I Berger, et al.
Pageof 18